Director

Nancy C. Andrews

Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital)·Charles River Laboratories International, Inc.

About

N

a

n

c

y

C

.

A

n

d

r

e

w

s

,

M

.

D

.

,

P

h

.

D

.

,

h

a

s

s

e

r

v

e

d

a

s

E

x

e

c

u

t

i

v

e

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

C

h

i

e

f

S

c

i

e

n

t

i

f

i

c

O

f

f

i

c

e

r

a

t

B

o

s

t

o

n

C

h

i

l

d

r

e

n

'

s

H

o

s

p

i

t

a

l

s

i

n

c

e

D

e

c

e

m

b

e

r

2

0

2

1

a

n

d

a

s

P

r

o

f

e

s

s

o

r

i

n

R

e

s

i

d

e

n

c

e

a

t

H

a

r

v

a

r

d

M

e

d

i

c

a

l

S

c

h

o

o

l

s

i

n

c

e

N

o

v

e

m

b

e

r

2

0

2

3

.

S

h

e

p

r

e

v

i

o

u

s

l

y

s

e

r

v

e

d

a

s

P

r

o

f

e

s

s

o

r

o

f

P

e

d

i

a

t

r

i

c

s

a

n

d

P

r

o

f

e

s

s

o

r

o

f

P

h

a

r

m

a

c

o

l

o

g

y

&

C

a

n

c

e

r

B

i

o

l

o

g

y

a

t

D

u

k

e

U

n

i

v

e

r

s

i

t

y

f

r

o

m

2

0

0

7

t

o

D

e

c

e

m

b

e

r

2

0

2

1

,

a

n

d

f

r

o

m

2

0

0

7

t

o

2

0

1

7

w

a

s

D

e

a

n

o

f

t

h

e

D

u

k

e

U

n

i

v

e

r

s

i

t

y

S

c

h

o

o

l

o

f

M

e

d

i

c

i

n

e

a

n

d

V

i

c

e

C

h

a

n

c

e

l

l

o

r

f

o

r

A

c

a

d

e

m

i

c

A

f

f

a

i

r

s

a

t

D

u

k

e

U

n

i

v

e

r

s

i

t

y

.

F

r

o

m

2

0

0

3

t

o

2

0

0

7

s

h

e

s

e

r

v

e

d

a

s

D

e

a

n

f

o

r

B

a

s

i

c

S

c

i

e

n

c

e

s

a

n

d

G

r

a

d

u

a

t

e

S

t

u

d

i

e

s

a

n

d

P

r

o

f

e

s

s

o

r

o

f

P

e

d

i

a

t

r

i

c

s

a

t

H

a

r

v

a

r

d

U

n

i

v

e

r

s

i

t

y

M

e

d

i

c

a

l

S

c

h

o

o

l

,

a

n

d

f

r

o

m

1

9

9

9

t

o

2

0

0

3

w

a

s

d

i

r

e

c

t

o

r

o

f

t

h

e

H

a

r

v

a

r

d

-

M

a

s

s

a

c

h

u

s

e

t

t

s

I

n

s

t

i

t

u

t

e

o

f

T

e

c

h

n

o

l

o

g

y

M

.

D

.

/

P

h

.

D

.

P

r

o

g

r

a

m

a

n

d

p

r

i

n

c

i

p

a

l

i

n

v

e

s

t

i

g

a

t

o

r

o

f

i

t

s

M

S

T

P

g

r

a

n

t

.

F

r

o

m

1

9

9

3

t

o

2

0

0

6

s

h

e

w

a

s

a

b

i

o

m

e

d

i

c

a

l

r

e

s

e

a

r

c

h

i

n

v

e

s

t

i

g

a

t

o

r

o

f

t

h

e

H

o

w

a

r

d

H

u

g

h

e

s

M

e

d

i

c

a

l

I

n

s

t

i

t

u

t

e

.

D

r

.

A

n

d

r

e

w

s

i

s

a

n

e

l

e

c

t

e

d

m

e

m

b

e

r

o

f

t

h

e

A

m

e

r

i

c

a

n

A

c

a

d

e

m

y

o

f

A

r

t

s

a

n

d

S

c

i

e

n

c

e

s

,

t

h

e

N

a

t

i

o

n

a

l

A

c

a

d

e

m

y

o

f

M

e

d

i

c

i

n

e

a

n

d

t

h

e

N

a

t

i

o

n

a

l

A

c

a

d

e

m

y

o

f

S

c

i

e

n

c

e

s

,

w

h

e

r

e

s

h

e

c

u

r

r

e

n

t

l

y

s

e

r

v

e

s

a

s

H

o

m

e

S

e

c

r

e

t

a

r

y

.

S

h

e

p

r

e

v

i

o

u

s

l

y

s

e

r

v

e

d

a

s

C

h

a

i

r

o

f

t

h

e

B

o

a

r

d

s

o

f

D

i

r

e

c

t

o

r

s

o

f

t

h

e

A

m

e

r

i

c

a

n

A

c

a

d

e

m

y

o

f

A

r

t

s

a

n

d

S

c

i

e

n

c

e

s

a

n

d

t

h

e

B

u

r

r

o

u

g

h

s

W

e

l

l

c

o

m

e

F

u

n

d

a

n

d

i

s

a

f

o

r

m

e

r

m

e

m

b

e

r

o

f

t

h

e

S

c

i

e

n

t

i

f

i

c

M

a

n

a

g

e

m

e

n

t

R

e

v

i

e

w

B

o

a

r

d

a

t

t

h

e

N

a

t

i

o

n

a

l

I

n

s

t

i

t

u

t

e

s

o

f

H

e

a

l

t

h

.

S

h

e

s

e

r

v

e

s

o

n

t

h

e

b

o

a

r

d

s

o

f

d

i

r

e

c

t

o

r

s

o

f

N

o

v

a

r

t

i

s

I

n

t

e

r

n

a

t

i

o

n

a

l

A

G

a

n

d

M

a

z

e

T

h

e

r

a

p

e

u

t

i

c

s

a

n

d

o

n

t

h

e

M

I

T

C

o

r

p

o

r

a

t

i

o

n

,

a

n

d

i

s

a

m

e

m

b

e

r

o

f

t

h

e

S

c

i

e

n

t

i

f

i

c

A

d

v

i

s

o

r

y

B

o

a

r

d

s

o

f

D

y

n

e

T

h

e

r

a

p

e

u

t

i

c

s

a

n

d

C

a

j

a

l

T

h

e

r

a

p

e

u

t

i

c

s

.

D

r

.

A

n

d

r

e

w

s

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

F

e

b

r

u

a

r

y

2

0

2

0

.

S

h

e

w

a

s

s

e

l

e

c

t

e

d

f

o

r

t

h

e

B

o

a

r

d

i

n

r

e

c

o

g

n

i

t

i

o

n

o

f

h

e

r

p

e

r

s

p

e

c

t

i

v

e

a

s

a

n

a

c

c

o

m

p

l

i

s

h

e

d

p

h

y

s

i

c

i

a

n

,

s

c

i

e

n

t

i

f

i

c

r

e

s

e

a

r

c

h

e

r

,

p

r

o

f

e

s

s

o

r

,

a

n

d

s

e

n

i

o

r

a

d

m

i

n

i

s

t

r

a

t

o

r

a

t

l

e

a

d

i

n

g

a

c

a

d

e

m

i

c

i

n

s

t

i

t

u

t

i

o

n

s

a

n

d

h

o

s

p

i

t

a

l

s

,

b

r

i

n

g

i

n

g

s

c

i

e

n

t

i

f

i

c

l

e

a

d

e

r

s

h

i

p

a

n

d

e

x

p

e

r

t

i

s

e

i

n

o

n

c

o

l

o

g

y

,

g

e

n

e

t

i

c

s

,

a

n

d

p

e

d

i

a

t

r

i

c

r

e

s

e

a

r

c

h

.

Since February 2020
Age 67
Tenure 6 yrs

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) SB Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) AC Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) PG Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) February 2020–present Current role
Boston Children's Hospital Executive Vice President and Chief Scientific Officer Dec 2021 - present
Harvard Medical School Professor in Residence Nov 2023 - present
Duke University Professor of Pediatrics and Professor of Pharmacology & Cancer Biology 2007 - Dec 2021
Duke University School of Medicine Dean of the School of Medicine and Vice Chancellor for Academic Affairs 2007 - 2017
Harvard University Medical School Dean for Basic Sciences and Graduate Studies and Professor of Pediatrics 2003 - 2007
Harvard-MIT M.D./Ph.D. Program Director and principal investigator of its MSTP grant 1999 - 2003
Howard Hughes Medical Institute Biomedical research investigator 1993 - 2006
Duke University School of Medicine Dean and Vice Chancellor for Academic Affairs 2007-2017
Harvard Medical School Dean for Basic Sciences and Graduate Studies

External roles

Organization Role Dates
Novartis International AG Director
Maze Therapeutics Director
MIT Corporation (MIT board of trustees) Member
Dyne Therapeutics Scientific Advisory Board member Since 2018
Cajal Therapeutics Scientific Advisory Board member Since Jan 2026
National Academy of Sciences Home Secretary
Novartis AG Director

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) Person Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person George Llado, Sr. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Craig B. Thompson Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo